Research Library
PRECLINICAL

MOTS-c

Also known as: MOTS-c, Mitochondrial ORF of the 12S rRNA type-c

Mitochondrial BiologyMetabolic SignalingCellular Stress
ClassificationMitochondrial-derived peptide.
Catalog / SKUMOTS-c · MX-MOTSC-020 · 20 mg
TargetsAMPK pathway; Metabolic stress-response programs

Molecular Overview

MOTS-c is a mitochondrial-derived peptide studied in metabolic-signalling and cellular-stress research, with reported links to AMPK-related pathways.

Mechanistic Background

Research associates MOTS-c with AMPK signalling and metabolic stress-response programs in experimental models.

What Researchers Study

Preclinical research has examined metabolic regulation, mitochondrial biology, and stress-response signalling.

Evidence Landscape

Current evidence level: PRECLINICAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Evidence is predominantly preclinical.

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.